Genscript Biotech
SEHK:1548
HK$ 12,81
+ HK$0,08 (0,63%)
12,81 HK$
+HK$0,08 (0,63%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

HK$0,21
Earnings Per Share
HK$2,14
Revenue Per Share
45,77%
Gross Margin %
HK$27,85 B
Market Cap
HK$4,43 B
Long-Term Debt
Earnings Per Share
HK$0,21
Revenue Per Share
HK$2,14
Gross Margin %
45,77%
Market Cap
HK$27,85 B
Long-Term Debt
HK$4,43 B

Financials

Year Year 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
EPS Earnings Per Share HK$0,21 HK$-1,10 HK$-0,62 HK$-0,64 HK$-0,76 HK$-0,40 HK$0,09 HK$0,15 HK$0,12 HK$0,09
Earnings Earnings HK$453,59M HK$-2,34B HK$-1,31B HK$-1,34B HK$-1,48B HK$-751,35M HK$165,18M HK$260,04M HK$203,02M HK$144,00M
RPS Revenue Per Share HK$2,14 HK$3,09 HK$2,31 HK$1,90 HK$1,55 HK$1,13 HK$0,99 HK$0,69 HK$0,53 HK$0,42
Revenue Revenue HK$4,62B HK$6,56B HK$4,88B HK$3,99B HK$3,03B HK$2,13B HK$1,81B HK$1,19B HK$889,67M HK$672,00M
OCF Operating Cash Flow HK$587,59M HK$-2,24B HK$-937,95M HK$-1,07B HK$-1,17B HK$0,00M HK$2,31B HK$166,96M HK$258,02M HK$152,18M
FCF Free Cash Flow HK$-942,84M HK$2,40B HK$-2,64B HK$-2,14B HK$-2,12B HK$-1,00B HK$1,76B HK$-61,19M HK$188,23M HK$100,26M
OM Operating Margin 1,56% 4,67% -70,00% -77,39% -52,33% -48,05% 2,21% 25,93% 21,73% 12,57%
GM % Gross Margin % 45,77% 48,29% 48,60% 57,65% 65,47% 65,95% 68,63% 68,52% 66,44% 65,83%
FCFS Free Cash Flow Per Share HK$-0,44 HK$-2,01 HK$-1,26 HK$-1,05 HK$-1,14 HK$-0,60 HK$1,03 HK$-0,04 HK$0,11 HK$0,08
LT Debt Long-Term Debt HK$4,43B HK$712,72M HK$567,23M HK$381,86M HK$1,26M HK$1,75M N/A N/A N/A N/A
Sha. Stocks 2.159,94M 2.124,05M 2.111,23M 2.095,69M 1.953,28M 1.878,38M 1.835,36M 1.733,61M 1.691,86M 1.600M
×